Mark Brönstrup

Summary

Affiliation: Aventis Pharma

Publications

  1. ncbi Absolute quantification strategies in proteomics based on mass spectrometry
    Mark Brönstrup
    Sanofi Aventis, Building G878, D 65926 Frankfurt, Germany
    Expert Rev Proteomics 1:503-12. 2004
  2. ncbi Cyclipostins, novel hormone-sensitive lipase inhibitors from Streptomyces sp. DSM 13381. II. Isolation, structure elucidation and biological properties
    László Vértesy
    Aventis Pharma Deutschland GmbH, Drug Innovation and Approval, Frankfurt Main, Germany
    J Antibiot (Tokyo) 55:480-94. 2002

Collaborators

Detail Information

Publications2

  1. ncbi Absolute quantification strategies in proteomics based on mass spectrometry
    Mark Brönstrup
    Sanofi Aventis, Building G878, D 65926 Frankfurt, Germany
    Expert Rev Proteomics 1:503-12. 2004
    ..Consequently, prominent application areas include biomarker quantification, the study of post-translational modifications such as phosphorylation or ubiquitination and the comparison of concentrations of interacting proteins...
  2. ncbi Cyclipostins, novel hormone-sensitive lipase inhibitors from Streptomyces sp. DSM 13381. II. Isolation, structure elucidation and biological properties
    László Vértesy
    Aventis Pharma Deutschland GmbH, Drug Innovation and Approval, Frankfurt Main, Germany
    J Antibiot (Tokyo) 55:480-94. 2002
    ..The outstanding characteristic of the cyclipostins is their strong anti-HSL activity, with IC50 values in the nanomolar range...